Cargando…
Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease
BACKGROUND: A subset of rheumatoid arthritis (RA) patients have detectable antibodies directed against the peptidyl-arginine deiminase (PAD) enzyme isoforms 3 and 4. Anti-PAD3/4 cross-reactive antibodies (anti-PAD3/4XR) have been shown to lower the calcium threshold required for PAD4 activation, an...
Autores principales: | Giles, Jon T., Darrah, Erika, Danoff, Sonye, Johnson, Cheilonda, Andrade, Felipe, Rosen, Antony, Bathon, Joan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047055/ https://www.ncbi.nlm.nih.gov/pubmed/24901704 http://dx.doi.org/10.1371/journal.pone.0098794 |
Ejemplares similares
-
Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans
por: Navarro-Millán, Iris, et al.
Publicado: (2016) -
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
por: Darrah, Erika, et al.
Publicado: (2018) -
Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis
por: Johnson, Cheilonda, et al.
Publicado: (2016) -
Peptidyl Arginine Deiminase Type 4 Gene Promoter Hypo-Methylation in Rheumatoid Arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020) -
Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor
por: Aliko, Ardita, et al.
Publicado: (2019)